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Summary 
Structural studies of cellular receptor molecules involved in immune recognition require the 
production of large quantities of the extracellular domains of these glycoproteins. The murine 
major histocompatibility complex (MHC) class II-restricted response has been extensively stud- 
ied by functional means, but the engineering and purification of the native, empty form of the 
most-studied murine MHC class II molecule, IA, has been difficult to achieve. IA molecules, 
which  are the routine  equivalent of human histocompatibility leukocyte antigen-DQ  mole- 
cules, have a low efficiency of chain pairing, which results in poor transport to the cell surface 
and in the appearance of mixed isotype pairs. We have engineered soluble IA molecules whose 
pairing has been forced by the addition of leucine zipper peptide dimers at their COOH-ter- 
minus. The molecules are secreted "empty" into the extracellular medium and can be loaded 
with single peptide  after purification.  These IA molecules have been expressed in milligram 
quantity for crystallization as well as for activation of T  cells  and measurement of MHC class 
II-T cell receptor interactions. 
T 
he  paradigm  for  studying  murine  MHC  class  II- 
restricted immune response has been systems in which 
the restricting element was an IA molecule (1). The three- 
dimensional structure of this particular MHC class II mole- 
cule and its human equivalent, HLA-DQ, is still unknown. 
The barrier to directly addressing this issue has been a lack of 
availability of large quantities of homogeneous purified IA 
molecules.  In contrast,  the  engineering of soluble and se- 
creted murine  IE  (2)  and human HLA-DtL molecules (3, 
4) has enabled structural studies to proceed. This latter ap- 
proach has not yielded satisfactory amounts of functionally 
active IA molecules. The addition ofa covalently linked pep- 
tide to the  end of the  IA-[3 chain  (5)  did not successfully 
overcome the expression problem (L. Teyton, unpublished 
observation). On the  other hand,  the promiscuity of both 
IA and  HLA-DQ chains  for pairing with  chains  of other 
class II molecules has been known for many years (6-8). Their 
ability to mismatch with IE and HLA-DtL chains, for ex- 
ample, is suggestive of a low affinity between homologous 
chains. As a consequence of this low affinity, the efficiency 
of assembly and transport is much lower for IA/HLA-DQ 
molecules than it is for IE/HLA-DR molecules (9,  10). We 
decided,  therefore,  to  test directly the  effect of enhanced 
IA ci and [3 chain pairing on the production of soluble se- 
creted IA  a molecules. 
In some proteins, such as the basic leucine  zipper tran- 
scription factors,  dimerization  is  mediated by coiled  coils 
composed of characteristic  seven residues  (heptad)  repeats 
(a to g) with hydrophobic residues at position a and d, and 
polar residues elsewhere (11,  12). These motifs can be trans- 
planted to other proteins, where dimerization through two 
amphipathic or-helices can lead to functional proteins (13). 
We have extended the COOH  terminus of each IA chain 
with such complementary leucine zipper peptides to force 
or-13 association. The resulting effect on dimerization, trans- 
port, and secretion was extremely beneficial, and we were 
able to isolate milligram quantities of highly purified mate- 
rial.  In addition, we have optimized conditions to load the 
purified IA molecules with single peptides. We have now 
shown that the peptide-loaded molecules are able to bind 
soluble T  cell receptor and to activate T  cells.  Finally, we 
have  used  IEF  to  demonstrate  the  formation  of a  stable 
complex between peptide and IA  a molecules. 
Materials and Methods 
eDNA Constructs, Transfection, and Purification.  Full-length  IA  a ot 
and 13 chain cDNAs were modified by PCtL using 3' primers en- 
coding the linker,  the thrombin cleavage site, the leucine  zipper 
peptide,  and a Sail cloning  site. An EcoRI site was added in the 
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main of the human mvariant chain was extended at its NH2-termi- 
nus by a stretch of six histidines and fused to the HLA-A2 signal se- 
quence by modifying the original cDNAs by PCR (14). The PCR 
fragments were cloned into the polyhnker of the metallothionein 
promoter-driven pRMHa3  vector  (15)  and  sequenced  by  dye 
terminator technique on an automated sequencer (model 373A; 
Apphed Biosystems, Foster City, CA). The modified cDNAs were 
cotransfected at equimolar ratio into Drosophila  melanogaster SC2 
cells along with a neomycin resistance gene (15) at a ratio of 1:60. 
Stable transfected cell hnes  were  derived by G418  selection in 
Schneider's medium over a period of 4 wk. Expression was tested 
3 d after copper sulfate induction by immunoprecipitation super- 
natant with MKD6 agarose beads (16), according to the described 
protocol  (15).  For large-scale preparation,  the  same  procedure 
was used, followed by a Mono Q  10/10 ion exchange chroma- 
tography and/or a  Superdex 200  gel filtration chromatography 
(Pharmacia, Piscataway, NJ). IAd-invariant chain complexes were 
purified from induced supernatants of triple-transfected cell lines 
by use of the same strategy. Soluble TCRs were made soluble by 
a  similar approach.  In  brief,  the  DNA  segment  encoding  the 
transmembrane region of both chains of the OVA-2 T cell recep- 
tor  (F.  Carbone,  unpublished  observations)  were  removed  by 
PCR mutagenesis using 3' oligonucleotides hybridizing to the 18 
base pairs ending the coding sequence of the constant domain and 
extended by the coding sequences  of their respective cytoplasmic 
tails and a polyhistidine tail. An EcoRI 5' and a SalI 3' cloning 
site were used for cloning into pRMHa3.  Transfections and se- 
lection were carried out as described for IA  d. The initial step of 
purification was  a  nickel-agarose affinity chromatography,  fol- 
lowed by ion exchange,  hydrophobic interaction chromatogra- 
phy, and gel filtration. All purified proteins were kept at 4~  in 
PBS plus 0.02% NaN  3 at high concentration (>5 mg/rnl). 
Biochemical Analysis, SDS-PA GE, and Antibodies.  Purifications 
were monitored by SDS-PAGE and Coomassie Brilliant Blue R 
250 staining. Precast 10-15% gradient acrylamide gels were rou- 
tinely used for this purpose (Bio-Rad, Hercules, CA). Two-dimen- 
sional gel electrophoresis was performed as described (8) with 3.5 
to 10.0 nonequilibrium pH gradient electrophoresis  (NEPHGE) 1 in 
the first dimension and a 12% SDS-PAGE in the second dimen- 
sion. 20 ~g of  purified protein was used per gel. Proteins were de- 
tected by Coomassie blue staining. 
Thrombin  digestion  was  performed  before  gel  filtration in 
morpholinoethanesulfonic acid buffer, pH 6.5, at 37~  for 60 rain 
with  10 -3 U  of the enzyme (Calbiochem-Novabiochem Corp., 
La Jolla, CA) per 10 p,g of IA molecules. Endoglycosidase-F di- 
gestion was performed in PBS, pH 7.4, for 60 rain at 37~  (1 U 
per 20 Ixg oflAd). 
The MHC class II--specific mAbs MKD6 (16) and M5-114 (17) 
were obtained from the American Type Culture Collection (R.ock- 
viile, MD). K24-199 (18) and 40B (19) were obtained from Drs. 
J.  Miller  (University of Chicago)  and  M.  Pierres  (INSERM- 
CNP,,S, Marseilles, France), respectively. Abs were purified from 
ascites by protein A affinity chromatography. 
Peptide Loading  and Native IEF.  Purified IA  d molecules were 
loaded with peptide immediately after elution at basic pH by add- 
ing 20 bLM of  free peptide and then neutralizing with 2 M glycine. 
The loaded molecules were subsequently dialyzed in PBS and fur- 
ther purified by gel filtration or, altematively, were dialyzed against 
IAbbreviations used in this paper: HA, hemagglutinin; NEPHGE, nonequi- 
librium pH gradient gel electrophoresis. 
50 mM Tris-HC1, pH 8.4, and purified by ion exchange chro- 
matography  and  gel  filtration.  The  three  peptides  used  were 
OVA323_339, hemagglutinin  (HA)126_138, and HEL46~j  (non-IA  a- 
specific peptide). Iad--Iis6_216  complexes were loaded with single 
peptides by incubating them with a 20-fold excess  of peptide at 
pH 5.5 for 60 rain at 37~  After neutralization with 4 M  Tris 
base, peptide complexes were purified by ion exchange chroma- 
tography and/or gel filtration. The loading experiment shown in 
Fig. 2  B  was analyzed 60  rain before the purification step.  All 
peptides were chemically synthesized by T-BOC chemistry on an 
Applied Biosystems instrument  and purified  on  a  C18  reverse 
phase column. IEF experiments were run on pH 3-10 Servalyte 
prenet gels (Serva Feinbiochemica GmbH and Co., Heidelberg, 
Germany)  on  a flat-bed temperature-controlled Isobox (Hoefer 
Scientific Instruments, San'Francisco, CA) at 2,000 V and stained 
by the Coomassie/copper sulfate method. 
T  Cell Assays.  T cell assays were carried out in triplicate in flat- 
bottom 96-well plates in which the different IA molecules were 
adsorbed overnight at 4~  in phosphate buffer at various concen- 
trations ranging from 1 to 0.125 p~g. T ceils were washed twice in 
PBS and incubated in DMEM, 0.05% BSA medium for 24 h at 2 ￿ 
104 cells per well. IL-2 secretion was measured using the NK cell 
assay (20). In brief, supernatants were harvested after 24 h and se- 
rially diluted before adding 5,000 NK IL-2/IL-4 indicator cells in 
a total volume of 100 p~l. After 24 h, NK cell cultures were pulsed 
with  1 p,  Ci of [3H]thymidine. Isotope incorporation was deter- 
mined the next day. Units are defined as the dilution of superna- 
tant to yield half-maximal stimulation of the indicator cells. 
Concentrations of IL-2 were determined by comparison with 
standard curves generated with recombinant IL-2 (Pharmingen, 
San Diego, CA). For each assay, the following IA molecules were 
tested: empty 1A  d, IA  d loaded with OVA323_339, IA  a loaded with 
HA126_138, IA  a plus 10 p~g of OVA323_339 peptide, IA  a plus 10 ~g of 
HAl26_138  peptide, and peptide alone. We used two T cell hybrido- 
mas for our functional assays: HA.126, a subclone of 6/22  126.3-2, 
specific for IAa-HA126_138 complexes (21), and DO 11.1.10,  a sub- 
clone of DO 11.10  (22) specific for IAd-OVA323_.339  complexes. 
Plasmon Resonance.  A  biosensor  (BIAcore 2000;  Pharmacia, 
Biosencor, Piscataway, NJ) was used for the measurements, and 
the data were analyzed with the BIAevaluation 2.1 package. The 
purified TCR molecules were immobilized to the dextran layer 
of the sensor chip by classic amine couphng.  The  different IA  a 
complexes and BSA were passed through the flow cell at 20 p~l per 
rain in PBS. Association and dissociation phases were fitted using 
the BIAevaluation 2.1 program. 
Results and Discussion 
We have successfully expressed a number of soluble and 
secreted HLA-DR  molecules in SC2  insect cells (L.  Tey- 
ton,  manuscript in preparation) but had failed to produce 
large quantifies of the murine IA molecules by using the same 
approach.  Production levels of IA from  stably transfected 
cell lines were between  10 and 50  p~g per liter of superna- 
tant, and purification was not feasible (L. Teyton,  unpub- 
lished observation). The strategy of fusing peptide residues 
that  correspond to  the  antigenic peptide sequence  to  the 
NH2-terminus  of the  13  chain has been recently described 
(5); however,  this approach did not increase levels of pro- 
duction.  Promiscuous  chain pairing by IA and  HLA-DQ 
has been  demonstrated by the  existence of mixed isotype 
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molecules on B  cell lines (6-8). The ability of IA molecules 
to form mixed  isotype  dimers suggests  a  low ot-~ pairing 
efficiency. 
An extensive  body of work has  recently emerged from 
the study of coiled coils based on leucine zipper motifs. The 
definition and usage of complementary acidic and basic se- 
quences in these  peptides  (11)  have allowed,  for example, 
the  production of dimeric  soluble  TCR.s  (13).  Since  each 
chain is  engineered  to have a  COOH-terminal  peptide  of 
opposite charge, the addition of the zipper produces only the 
correctly paired  heterodimeric  product.  We  have  applied 
this technology to the expression of soluble IA  a molecules. 
As shown in Fig. 1 A, the IA ot and [3 chain cDNAs have 
been truncated  at the boundary between  the  second con- 
stant domain and the transmembrane domain and extended 
at their 3' ends by the coding sequences of either the acidic 
or the basic leucine zipper peptides  and a thrombin cleav- 
age site.  The modified cDNAs were cloned into an induc- 
ible metallothionein-driven vector, pRMHa3  (15), and co- 
transfected into SC2 cells along with a neomycin resistance 
gene  to  produce  a  stable  cell  line.  500-1500  lxg/1  of IA 
dimers  were  purified  to homogeneity by affinity chroma- 
tography and subsequent ion exchange chromatography and/ 
or gel filtration.  Fig.  1 B, panel  1, shows the two-dimen- 
sional gel electrophoresis  analysis of IA heterodimers  pro- 
duced in this system, with the et chain shifted to the acidic 
side of the pH gradient owing to the addition of the acidic 
peptide, and the ~  chain shifted to the basic end. A  60-rain 
thrombin  digest  efficiently  removed  the  leucine  zipper 
peptides  from >80%  of the molecules  (Fig.  1 B, panel  2). 
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Figure  1.  (A) Schematic outline of the cDNA constructs used for the 
production of  soluble IA  a molecules. The sequences of  the linker, throm- 
bin cleavage  site, and acidic/basic leucine zipper peptides are indicated in 
single-letter amino acid code. FL, fuU-length; Tm, transmembrane; Cyt, 
cytoplasmic; O, truncated. (B) Two-dimensional gel analysis of  the empty 
soluble, purified IA  a molecules. (I) IA  d molecules  with leucine zipper; (2) 
IA  d molecules after thrombin cleavage of the leucine zipper; (3) endogly- 
cosidase-F digestion of the IA  d molecules; (4) IAa-invariant chain com- 
plexes; (5) IAa-invariant chain complexes after thrombin digestion; (6) 
schematic representation and assignment of the different spots seen in 1 
through 5. ~x, et chain; o~' and or", deglycosylated  a chain; [~, 13 chain; ~', 
deglycosylated (3 chain; Ii, invariant chain; a  thrombin, et chain after the 
removal of the acidic peptide by thrombin cleavage; [3 thrombin, [3 chain 
after removal of the basic peptide by thrombin cleavage. Directions of 
NEPHGE  and SDS-PAGE  gels are indicated by arrows. Table  1.  Sequendng of Empty and Peptide-loaded  IA s Molecules 
Cycle 
IA  d molecule  Chain or peptide  2  3  4  5  6  7  8 
Empty IA  a 
lAd-OVA 
lAd-HA 
o~  D(8)  D(12)  I(8)  /  A(8)  D(8)  / 
13  N(16)  /  E(12)  /  H(6)  F(8)  / 
p  /  /  /  /  /  /  / 
o~  D(22)  D(27)  I(7)  E(19)  A(19)  D(15)  H(I2) 
[3  N(25)  /  E(15)  /  H(16)  F(11)  V(21) 
p  /  Q(22)  A(13)  V(29)  H(16)  A(12)  A(18) 
o~  D(23)  D(31)  I(9)  E(14)  A(15)  /  H(7) 
[3  N(20)  /  E(21)  G(16)  H(9)  F(11)  V(16) 
p  N(21)  T(18)  N(16)  G(16)  V(14)  T(7)  / 
For each sequence the amount recovered per cycle is indicated in parenthesis in picomoles. The slashes indicate residues that did not appear in the se- 
quencing, ix stands for the sequence of  the cx chain, [3 for the sequence of the/3 chain, and p for the sequence of  the peptide. Amino acids are in sin- 
Fie-letter code. 
We noticed that the [3 chain thrombin site was consistently 
more accessible than its o~ chain counterpart and that it was 
readily  removed  by  a  10-rain  protease  digestion.  On  the 
other hand, the ix chain site needed 30-45 rain to be cleaved. 
Endoglycosidase-F (or PNGase;  data  not shown)  was used 
to assess the state of glycosylation of the expressed IA mole- 
cules.  Partial  digest with  endoglycosidase-F removed the  2 
N-linked sugars of the ix chain and the single site  of the  [3 
chain (Fig.  1 B, panel 3). 
A  native,  folded conformation of the purified  IA mole- 
cules was then confirmed by antibody reactivity and func- 
tional studies. The following antibodies, as shown by ELISA 
(data not shown),  all  reacted with  the recombinant mole- 
cules: MKD6  (16), M5-114  (17),  40-B (19),  and K24-199 
(18). 
In  addition,  to  confirm  the  correct  folding  of the  IA 
dimers, we were able to demonstrate their ability to associ- 
ate with the invariant chain (li)  (Fig.  1 B, panels  4 and 5). 
A  human soluble form of Iip31  (14), extended at its NH2- 
terminus  by  a  stretch  of six  histidines,  was  cotransfected 
into  SC2  cells  together  with  IA ix  and  13  leucine  zipper 
cDNAs, and the association of their products was tested by 
immunoprecipitating  complexes  through  the  Ii  histidines 
by use ofnickel-agarose beads. As seen in Fig. 1 B, panel 4, 
IA ix,  ]3,  and  Ii  did  associate  together,  showing  that  the 
conformation of the  IA dimer  was  comparable  to  that  of 
normal IA molecules. Furthermore, the leucine zipper could 
be removed from these  complexes by thrombin  digestion 
without cleaving Ii (Fig.  1 B, panel 5). The equimolar ratio 
among ix,  13, and Ii chains retained in these complexes was 
confirmed by protein sequencing of size-purified material. 
The next step was to show that the recombinant mole- 
cules were empty when secreted and were able to bind pep- 
tides.  The absence  of peptide  in the purified  material  was 
confirmed by protein sequencing.  The first 12 cycles could 
only detect the sequences of IA ix and [~ chains without the 
presence of other sequences (Table  1). In addition, no SDS 
stable dimers  (23-25)  could be detected by SDS-PAGE of 
the  purified  material.  However,  we  cannot  exclude  defi- 
nitely that some low abundancy, non-SDS-stabilizing pep- 
tides were present in these preparations of purified IA  d mole- 
cules and fell below the level of detection of the techniques 
that we used to determine  the emptiness.  These molecules 
could be loaded efficiently with single peptides immediately 
after the affinity purification step to avoid the possibility of 
denaturation  and aggregation (26).  Since the  two peptides 
we used, OVA323_339 and HA126_138, do not confer SDS sta- 
bility to the  dimers  (L. Teyton,  unpublished  observation), 
we  examined  peptide  loading  by  native  IEF.  Fig.  2  A 
shows  the  shift  in pI  of the  IA molecule  induced  by the 
binding of the two peptides  (pls of 5.2 and 5.4 for HA and 
OVA peptides,  respectively).  The  appearance  of a limited 
number of sharp bands in these samples corresponds to the 
peptide-loaded  IA  d  molecules,  whereas  empty  IA  mole- 
cules  and  IA  molecules  plus  a  non-lAd-binding  peptide 
(HEL46_61  peptide)  do  not  focus within  a  narrow  range. 
The broad focusing range is explained by the partial  dena- 
turation  of the  empty dimers  and/or  by the  loading  of a 
Figure  2.  Peptide loading of empty IA  d molecules and stimulation of T cell hybridomas by purified, immobilized IA-peptide complexes. (A) Empty IA  d 
molecules were loaded with single peptides after elution from the affinity column and analyzed by native IEF electrophoresis (top). Sharp bands correspond- 
ing to peptide-loaded IA  a molecules appeared only with HA126-t38 and OVA323~339 peptides but not with non-IAa-binding peptides such as HEL46q,> 
These complexes were used to stimulate DO 11.1.10 T cells and HA. 126 T cells. Purified IAe-OVA complexes (solid squares) and purified IAa-HA com- 
plexes (solid triangles) were used in each experiment. Negative controls included empty IA  d and empty IA  a plus 10 btg of  free peptide. They all gave back- 
gound levels of stimulation, as the nonspecific IAd-peptide complex did. (/3) Formation of  functional IAd-peptide complexes by acidic treatment oflA  d- 
2090  Role of Chain Pairing in Producing Functional Soluble IA MHC Class lI Molecules Ii complexes. IAd-Ii56_216 complexes (Cx) were incubated with different peptides at pH 5.5 (see Materials and Methods for details) and analyzed by native 
IEF (left). These complexes were used to stimulate DOl1.1.10  T  cells  (right).  IAd-OVA complexes made from IAd-Ii complexes (open  circles) and IA  d- 
OVA complexes made from freshly eluted empty IA  a molecules (solid  squares)  were equally efficient at stimulating DOl1.1.10  T  cells. Non-stimulatory 
ligands included empty IA  d molecules, IA't-Ii complexes, IAa-HA complexes made from either empty IA  a molecules or IAd-Ii complexes, and IAd-Ii 
complexes plus 10 ~g of  free peptide. They all gave background levels of  stimulation. 
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spectrum of low affinity peptides that are undetectable by 
protein sequencing, as mentioned above. The loading with 
single peptide was confirmed by NH2-terminal protein se- 
quencing and appeared to be complete and stochiometric 
(equimolar ratios of c~ and [3 chains and peptide; see Table 
1).  Peptide-loaded IA  d molecules were  easily  purified by 
ion exchange chromatography and eluted as a single peak 
or a close doublet of sharp peaks (data not shown). 
The native structure and functionality of these IA-pep- 
tide complexes were confirmed by examining their interaction 
with the TCR. First,  we examined this interaction in vivo 
by T  cell assay; then, we looked at its binding characteris- 
tics in vitro by using surface plasmon resonance. The pre- 
formed  IAa-peptide  complexes  were  adsorbed  onto  the 
plastic  wells of 96-well microtiter plates  at increasing con- 
centrations ranging from 0.125  ~g to  1  ~g per well and 
used  to  stimulate  T  cell  hybridomas.  For both  the  IA  d- 
OVA-restricted  hybridoma  (DO.11.1.10  [22])  and  the 
IAd-HA-restricted  hybridoma  (HA-126  [21]),  maximal 
stimulation  was  reached for doses of ~0.25  b~g per well. 
This is considerably lower than the dose used for half-max- 
imal stimulation for the published IA  d [3 chain peptide hy- 
brid molecules, which could not reach a plateau  of stimula- 
tion  at  0.5  ~g  per  well  (5).  All  of the  following  other 
combinations failed to induce T  cell activation: empty IA  a, 
empty IA  d plus free peptide, IA  d plus non-specific peptide 
complex, and peptide alone.  The removal of the leucine 
zipper had no effect on these T cell assays (data not shown). 
Empty IA  d molecules failed to bind free peptide when the 
binding was done more than 24 h after the purification of  the 
MHC molecule (L. Teyton, manuscript in preparation). IA  d 
molecules complexed with Ii56_216  were  loaded with single 
peptides by acidic treatment and used in an identical T  cell 
assay. The stimulatory capacity of the IA  d molecules from 
either source was comparable (Fig. 3 B). 
We  directly measured  the  af[inity of IAa-OVA  com- 
plexes  for  a  soluble  purified  IAa-OVA-restricted  TCR 
(OVA-2, VoL2 V[35; F. Carbone, C. Scott, and L. Teyton, 
unpublished sequences). 
1,000 RUs  of TCR were immobilized on the  dextran 
layer of the  CM5  chip,  and  concentrations  of IA  a com- 
plexes ranging from 1.875 to 30 ~M were flowed over it. 
As seen in Fig.  3 A, only the IAa-OVA complexes gave a 
measurable signal, whereas the IAa-HA complexes gave back- 
ground signal  on this surface. On a control surface, coated 
with B3, an anti-Kb-OVA TCR (27), the IAo-OVA com- 
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Figure 3.  Binding of IA&OVA complexes to immo- 
bilized  OVA-2 soluble  TCR analyzed  by surface plas- 
mon resonance.  Purified soluble OVA-2 and B3 TCRs 
were coupled to a CM5 chip by amine chemistry. BSA, 
IA&OVA complexes, and IAa-HA complexes, at succes- 
sive twofold dilutions,  ranging  from 30  to  1.875 IxM, 
were caused to flow through the flow cell at 20 Ixl/min. 
(A) The overlay of the different sensograms is shown for 
each  analyte on the OVA-2 surface and  for IA~-OVA 
complexes on the B3 surface. Only IAa-OVA complexes 
on the  OVA-2 surface exhibited stigmates of binding. 
(B) Fit of the association and dissociation phases of IA  a- 
OVA complexes  (30 IxM) binding to OVA-2 TCRs to 
theoretical  models  (solid  interpolated  curve).  The associa- 
tion was fitted on a single association site model (A +  B 
=  AB), whereas the dissociation was fitted on a two par- 
allel dissociations model (AiBj =  Ai +  Bj). 
plexes  exhibited  no  sign  of binding.  The  association  rate 
was  derived by  fitting  the  experimental  curve  on  a  single 
association site model (Fig. 3  B) and was relatively fast for a 
TCR-MHC  interaction  with  a Kon of 2.96  ￿  104  M-1/s 
(28-30).  The dissociation phase could be fitted satisfactorily 
on a single-site dissociation model, but the best fit was ob- 
tained on a model accounting for the parallel dissociation of 
two sites (Fig. 3  B) with a very slow Kd of 6.19  ￿  10 -3 s -1 
and  a  very fast  one  at  0.164  s -1.  The  slow  component  of 
this  dissociation  could be  accounted  for by  some  nonspe- 
2093  Scott et al. 
cific  binding  of the  IA  molecules  to  the  dextran  surface, 
whereas the fast one likely represents the dissociation of the 
specific TCR-MHC  interaction. 
In conclusion,  we  are able to produce  empty and  func- 
tional IA  a molecules by improving the efficiency of correct 
pairing between the ot and [5 chains of the IA dimer, owing 
to the addition of a leucine zipper. The opportunity to load 
them efficiently with single peptides now allows us to study 
individual IA-peptide interactions  as we have been able to 
do for MHC  class I peptide complexes (31).  In our experi- ments, the addition of an antigenic peptide sequence to the 
NH2-terminus of the [3 chain did not increase the levels of 
production, suggesting that the presence of the peptide did 
not lead to an increase in correct folding and intracellular 
transport of IA  d molecules. The limited eflficiency of pair- 
ing of IA chains appears to be the main limiting factor for 
their  expression  and  transport.  The  availability of these 
larger quantifies of  purified MHC and TCR molecules should 
enable us to embark on X-ray crystallographic studies. 
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